GenSight Biologics S A : Convening notice – 2023 General Meeting
CONVENING OF THE COMBINED GENERAL MEETING ON JUNE 21, 2023 GENSIGHT BIOLOGICS A French Société Anonyme ... | May 31, 2023
Source: marketscreener.com
Temporary Authorizations News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Temporary Authorizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Temporary Authorizations Today - Breaking & Trending Today
GenSight Biologics S.A.: GenSight Biologics Reports Full Year 2022 Consolidated Financial Results
Efforts to reduce cash burn in 2023 while securing LUMEVOQ manufacturing and preparing for commercial launch in Europe in H1 2024 PPQ campaign to start early May 2023 with results expected
Source: finanznachrichten.de
ABIONYX Pharma Announces That the French Drug Safety Agency (Agence Nationale de Sécurité du Médicament or ANSM) Has Granted a Compassionate Access Authorization for the bio-HDL (CER-001) in COVID-19 Disease
Regulatory News: ABIONYX Pharma (FR0012616852 ABNX PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today announces
Source: finanznachrichten.de
ABIONYX Pharma Announces That the French Drug Safety Agency (Agence Nationale de Sécurité du Médicament or ANSM) Has Granted a Compassionate Access Authorization for the bio-HDL (CER-001) in COVID-19 Disease
03.01.2022 - Regulatory News: ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today announces that the French Drug Safety Agency (Agence ...
Source: wallstreet-online.de